德国AyoxxA  
Ayoxxa是新加坡国立大学的衍生公司，生产从一滴血同时验出和测量作为疾病指标的多种蛋白质。这家获得基金会资助的公司去年在奥地利的一项全球生命科学商业计划比赛中赢得冠军。
 
AyoxxA, an international biotech company based in Cologne, Germany, and Singapore, has developed a proprietary technology platform for multiplexed protein analysis. Core to this cutting-edge technology are “In-situ Encoded Bead-based Arrays” (IEBA) which allow simultaneous, precise and cost effective protein analysis in very small sample volumes.

These novel biochips allow users to combine high throughput screening and multiplexed assay formats at the same time and thus have the potential to revolutionize applications in biomedical research, pharmacological screening, and diagnostics.

AyoxxA was founded as a spin-off of the National University of Singapore (NUS) in 2010. The company received multiple grants in Singapore from the National Research Foundation (NRF), the SMART Innovation Centre (Singapore MIT Alliance for Research and Technology), and SPRING's Technology Enterprise Commercialisation Scheme (TECS). It established corporate headquarters in Cologne in Spring 2012 and continues to run operations in Singapore.